MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/infdis/jix265

Медицинская библиотека · The Journal of infectious diseases · 2017

Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy.

Henrich Timothy J, Hobbs Kristen S, Hanhauser Emily, Scully Eileen, Hogan Louise E, Robles Yvonne P, Leadabrand Kaitlyn S, Marty Francisco M, Palmer Christine D, Jost Stephanie, Körner Christian, Li Jonathan Z, Gandhi Rajesh T, Hamdan Ayad, Abramson Jeremy, LaCasce Ann S, Kuritzkes Daniel R

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Systemic chemotherapies for various malignancies have been shown to significantly, yet transiently, decrease numbers of CD4+ T lymphocytes, a major reservoir for human immunodeficiency virus type 1 (HIV-1) infection. However, little is known about the impact of cytoreductive chemotherapy on HIV-1 reservoir dynamics, persistence, and immune responses.

METHODS

We investigated the changes in peripheral CD4+ T-cell-associated HIV-1 DNA and RNA levels, lymphocyte activation, viral population structure, and virus-specific immune responses in a longitudinal cohort of 15 HIV-1-infected individuals receiving systemic chemotherapy or subsequent autologous stem cell transplantation for treatment of hematological malignancies and solid tumors.

RESULTS

Despite a transient reduction in CD4+ T cells capable of harboring HIV-1, a 1.7- and 3.3-fold increase in mean CD4+ T-cell-associated HIV-1 RNA and DNA, respectively, were observed months following completion of chemotherapy in individuals on antiretroviral therapy. We also observed changes in CD4+ T-cell population diversity and clonal viral sequence expansion during CD4+ T-cell reconstitution following chemotherapy cessation. Finally, HIV-1 DNA was preferentially, and in some cases exclusively, detected in cytomegalovirus (CMV)- and Epstein-Barr virus (EBV)-responsive CD4+ T cells following chemotherapy.

CONCLUSIONS

Expansion of HIV-infected CMV/EBV-specific CD4 + T cells may contribute to maintenance of the HIV DNA reservoir following chemotherapy.

Для цитирования: Henrich Timothy J, Hobbs Kristen S, Hanhauser Emily, Scully Eileen, Hogan Louise E, Robles Yvonne P, Leadabrand Kaitlyn S, Marty Francisco M, Palmer Christine D, Jost Stephanie, Körner Christian, Li Jonathan Z, Gandhi Rajesh T, Hamdan Ayad, Abramson Jeremy, LaCasce Ann S, Kuritzkes Daniel R. Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy.. The Journal of infectious diseases. 2017. DOI: 10.1093/infdis/jix265.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.